Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
LOXL2 alleviates post-traumatic knee osteoarthritis and pain.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
LOXL2 Deletion Triggers TMJ Osteoarthritis While Overexpression Protects Against NF-κβ-Induced Chondrocyte Apoptosis.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
LOXL2 alleviates post-traumatic knee osteoarthritis and pain.
Journal: Journal of orthopaedic translation
Published: March 27, 2025
LOXL2 deletion triggers TMJ osteoarthritis, while overexpression protects it from NF-κB-induced chondrocyte apoptosis.
Journal: International journal of oral science
Published: March 24, 2025
Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition.
Journal: Molecular cancer research : MCR
Published: April 28, 2021
LOXL2 promotes aggrecan and gender-specific anabolic differences to TMJ cartilage.
Journal: Scientific reports
Published: February 17, 2020
Lysyl Oxidase-Like 2 Protects against Progressive and Aging Related Knee Joint Osteoarthritis in Mice.
Journal: International journal of molecular sciences
Published: August 12, 2019
Showing 1-7 of 7
Last Updated: 09/26/2026